Minerva Neurosciences, Inc.
USD5.49
+0.06 (+1.10%)
CEO
Remy Luthringer
IPO Date
2014-07-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.47
Prev. Close
$5.43
Day Low
$5.41
Day High
$5.77
52W Low
$1.57
52W High
$12.46
Market Cap
$0.04B
Volume
0.13M
| 11.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 105.4% | -52.7% | 0.00 | 12.57 | -1.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 160.3% | -58.3% | 0.00 | 29.15 | -0.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -625.7% | -64.7% | 0.00 | 22.07 | -0.7 |
| 31 Dec 2020 | FY | 100.0% | 4.7% | 3.7% | 3.4% | 0.00 | 8.68 | 49.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -259.8% | -93.1% | 0.01 | 7.11 | -3.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -55.6% | -36.1% | 0.00 | 24.94 | -5.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -24.0% | -17.2% | 0.03 | 18.94 | -7.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -29.3% | -23.4% | 0.08 | 8.66 | -11.9 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 7.9% | -9.8% | 0.00 | 4.87 | -1.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 10.1% | -10.7% | 0.00 | 6.15 | -1.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 12.9% | -11.4% | 0.00 | 9.21 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 16.6% | -11.5% | 0.00 | 7.85 | -1.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -103.9% | 52.6% | 0.00 | 6.23 | 0.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 18.5% | -17.8% | -1.95 | 7.47 | -0.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 23.4% | -17.0% | -2.30 | 12.58 | -0.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 31.7% | -15.9% | 0.00 | 12.57 | -1.3 |